StockComparison Logo
vs

CGTX vs EXFY

Comparison between Cognition Therapeutics Inc (CGTX, Company) and Expensify Inc - Class A (EXFY, Company).

CGTX is from the Healthcare sector, while EXFY is from the Technology sector.

5-Year PerformanceCGTX has outperformed EXFY, delivering a return of -39.6% compared to -53.2%

CGTX vs EXFY - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
CGTX
$102M
Winner
EXFY
$117M
Max Drawdown
Winner
CGTX
98.16%
EXFY
98.46%
Sharpe Ratio
Winner
CGTX
1.60
EXFY
-0.70
5Y Beta
CGTX
1.90
Winner
EXFY
1.23
Industry
CGTX
Biotechnology
EXFY
Software - Application
P/E Ratio
CGTX
-2.40
Winner
EXFY
-6.95
Debt to Equity
CGTX
0.00%
EXFY
0.00%
Free Cash Flow Yield
CGTX
-19.88%
Winner
EXFY
13.13%
P/S Ratio
CGTX
N/A
EXFY
0.91
P/B Ratio
CGTX
3.46
Winner
EXFY
0.87

CGTX vs EXFY - Historical Returns

Returns include dividend reinvestment.

1M
CGTX
+2.54%
Winner
EXFY
+30.41%
3M
CGTX
+12.04%
Winner
EXFY
+54.60%
6M
CGTX
-28.40%
Winner
EXFY
-21.74%
1Y
Winner
CGTX
+292.86%
EXFY
-46.38%
5Y(CAGR)
Winner
CGTX
-39.58%
EXFY
-53.22%
Max(CAGR)
Winner
CGTX
-39.58%
EXFY
-53.22%

CGTX vs EXFY - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearCGTXEXFY
2026-17.69%-13.10%
2025+86.70%-56.86%
2024-63.85%+36.73%
2023-9.76%-71.21%
2022-66.40%-78.13%
2021-50.51%+7.16%

CGTX vs EXFY Drawdown Comparison

The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.

The maximum drawdown for EXFY was -98.46%, occurring on Mar 17, 2026. This drawdown has not yet recovered.

The current CGTX drawdown is -90.68%. The current EXFY drawdown is -97.40%.

RankCGTXEXFY
#1-98.16%
Nov 9, 2021 - May 30, 2025
-98.46%
Nov 26, 2021 - Mar 17, 2026
#2-6.81%
Oct 8, 2021 - Nov 9, 2021
-10.04%
Nov 12, 2021 - Nov 24, 2021

Correlation

Correlation between CGTX and EXFY is 0.86 which considered as a strong positive correlation - the stocks tend to move together.

0.86
-101

Select Stocks to Compare